Eris Lifesciences (BOM:540596) Days Sales Outstanding : 70.37 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Days Sales Outstanding?

Eris Lifesciences's average Accounts Receivable for the three months ended in Mar. 2024 was ₹4,220 Mil. Eris Lifesciences's Revenue for the three months ended in Mar. 2024 was ₹5,473 Mil. Hence, Eris Lifesciences's Days Sales Outstanding for the three months ended in Mar. 2024 was 70.37.

The historical rank and industry rank for Eris Lifesciences's Days Sales Outstanding or its related term are showing as below:

BOM:540596' s Days Sales Outstanding Range Over the Past 10 Years
Min: 13.97 Med: 26.96 Max: 62.01
Current: 62.01

During the past 12 years, Eris Lifesciences's highest Days Sales Outstanding was 62.01. The lowest was 13.97. And the median was 26.96.

BOM:540596's Days Sales Outstanding is ranked better than
59.42% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs BOM:540596: 62.01

Eris Lifesciences's Days Sales Outstanding increased from Mar. 2023 (67.35) to Mar. 2024 (70.37).

Eris Lifesciences Days Sales Outstanding Historical Data

The historical data trend for Eris Lifesciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Days Sales Outstanding Chart

Eris Lifesciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

41.54

45.50

41.48

49.82

65.50

Eris Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															67.35	58.06	63.76	66.01	70.37

Competitive Comparison of Eris Lifesciences's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Eris Lifesciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eris Lifesciences's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eris Lifesciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Eris Lifesciences's Days Sales Outstanding falls into.

Eris Lifesciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Eris Lifesciences's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (2927.09	+	4220.24)	/	2 )	/	19912.95	*	365
=	3573.665					/	19912.95	*	365
=	65.50

Eris Lifesciences's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	4220.24)	/	1 )	/	5472.65	*	365 / 4
=	4220.24					/	5472.65	*	365 / 4
=	70.37

Eris Lifesciences (BOM:540596) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Eris Lifesciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Eris Lifesciences (BOM:540596) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

ERIS:India

Address

Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054

Website

https://www.eris.co.in

Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (BOM:540596) Headlines

No Headlines